Case Report: IL-6 suppression: a potential strategy for mitigating severe immune-related adverse events in nivolumab and ipilimumab therapy for malignant pleural mesothelioma. [PDF]
Yanagisawa A +4 more
europepmc +1 more source
Impact of Neoadjuvant and Adjuvant Pleural Intensity-Modulated Radiotherapy in Multimodality Treatment for Malignant Pleural Mesothelioma. [PDF]
Mosleh B +13 more
europepmc +1 more source
Volatile organic compounds in exhaled human breath for the diagnosis of malignant pleural mesothelioma: a meta-analysis. [PDF]
Zhao T +6 more
europepmc +1 more source
Prognostic Value of Chest CT Volumetric Analysis in Patients with Malignant Pleural Mesothelioma. [PDF]
Baratella E +9 more
europepmc +1 more source
Immunotherapy for advanced and recurrent malignant pleural mesothelioma. [PDF]
Haugaard AK +5 more
europepmc +1 more source
MALIGNANT PLEURAL MESOTHELIOMA
D.S. Kahn, A. Glay, P. Madore
openaire +1 more source
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [PDF]
Felip, E. +3 more
core
A Case of Malignant Pleural Mesothelioma With Unknown Asbestos Exposure. [PDF]
Paremuzyan A, Onwubuya E, Mathews J.
europepmc +1 more source
Early severe immune-related pneumonitis, hepatitis, and agranulocytosis with radiographic response in sarcomatoid malignant pleural mesothelioma treated with nivolumab and ipilimumab: a case report highlighting dual liver biopsies and rechallenge decision-making. [PDF]
Oba T +8 more
europepmc +1 more source
Hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma after cytoreductive surgical procedures: a systematic review. [PDF]
Elsayed HH +4 more
europepmc +1 more source

